Abstract
The ErbBreceptor family has been used as therapeutic target for treatment of several types of cancer. Biflorin is a natural ο-naphthoquinone with anticancer properties. Herein, we described the effect of biflorin on cell growth and EGFR expression in SK-Br3 human breast cancer cell line with high EGFR expression. Biflorin significantly inhibited breast cancer cell growth, in a dose- and time-dependent manner as determined by the Alamar Blue assay. Noncitotoxicity were observed in normal MCF-10A breast cell line. Furthermore, biflorin inhibited EGFR expression in a dose-dependent manner. Biflorin can be used as a drug lead for new molecules against EGFR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
